Safety and Efficacy Study of Non-Surgical MC Device for Adolescent Male Population Including Contraindicated Subjects
Launched by MINISTRY OF HEALTH, RWANDA · Oct 19, 2015
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
Rwanda Has also completed a third study to assess the safety and efficacy of MC when performed by nurses using PrePex in both rural and urban hospitals, Device safety was assessed by the rate of clinical adverse events and device-related incidents attributed to the PrePex device and its procedures, the study report was shared with the WHO Male Circumcision Technical Advisory Group. On February 2011 the WHO provided Rwanda with recommendation to phase in MC scale up with the PrePex device on adults. Moreover the WHO recommended Rwanda to study the PrePex for use on adolescent population, sta...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Adolescent Males in ages - 10 to 17 years
- • Uncircumcised
- • Subject wants to be circumcised
- • Subject assent to the procedure
- • Legal guardian consent to the procedure
- • Subject with or without the following conditions: Preputial adhesions and /or narrow foreskin/Phimosis
- • Able to understand the study procedures and requirements
- • Agrees to abstain from sexual intercourse for 8 weeks after circumcision
- • Agrees to abstain from masturbation for at least 2 weeks after Removal
- • Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 7 weeks post removal (8 weeks total)
- • Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
- • Subject agrees to anonymous video and photographs of the procedure and follow up visits.
- Exclusion Criteria:
- • Legal guardian withholds consent
- • Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
- • Subject with the following diseases/conditions: paraphimosis, warts under the prepuce, torn or tight frenulum, hypospadias, epispadias
- • Known bleeding / coagulation abnormality, uncontrolled diabetes
- • Subject that to the opinion of the investigator is not a good candidate
- • Subject does not agree to anonymous video and photographs of the procedure and follow up visits.
Trial Officials
Vincent Mutabazi, M.D.
Principal Investigator
Ministry of Health, Rwanda
About Ministry Of Health, Rwanda
The Ministry of Health of Rwanda is a pivotal governmental body dedicated to enhancing the health and well-being of the Rwandan population through the implementation of effective public health policies and initiatives. As a clinical trial sponsor, the Ministry plays a crucial role in advancing medical research and innovation, ensuring that trials are conducted ethically and in compliance with national and international standards. By fostering collaboration with local and international partners, the Ministry seeks to address pressing health challenges, improve healthcare delivery, and contribute to the global body of medical knowledge, ultimately aiming to enhance health outcomes for all Rwandans.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kigali, , Rwanda
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials